Literature DB >> 23702032

Muscle type and fiber type specificity in muscle wasting.

Stefano Ciciliot1, Alberto C Rossi, Kenneth A Dyar, Bert Blaauw, Stefano Schiaffino.   

Abstract

Muscle wasting occurs in a variety of conditions, including both genetic diseases, such as muscular dystrophies, and acquired disorders, ranging from muscle disuse to cancer cachexia, from heart failure to aging sarcopenia. In most of these conditions, the loss of muscle tissue is not homogeneous, but involves specific muscle groups, for example Duchenne muscular dystrophy affects most body muscles but spares extraocular muscles, and other dystrophies affect selectively proximal or distal limb muscles. In addition, muscle atrophy can affect specific fiber types, involving predominantly slow type 1 or fast type 2 muscle fibers, and is frequently accompanied by a slow-to-fast or fast-to-slow fiber type shift. For example, muscle disuse, such as spinal cord injury, causes type 1 fiber atrophy with a slow-to-fast fiber type shift, whereas cancer cachexia leads to preferential atrophy of type 2 fibers with a fast-to-slow fiber type shift. The identification of the signaling pathways responsible for the differential response of muscles types and fiber types can lead to a better understanding of the pathogenesis of muscle wasting and to the design of therapeutic interventions appropriate for the specific disorders. This article is part of a Directed Issue entitled: Molecular basis of muscle wasting.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cachexia; Muscle atrophy; Muscle disuse; Muscle fiber types; Muscular dystrophies; Sarcopenia

Mesh:

Year:  2013        PMID: 23702032     DOI: 10.1016/j.biocel.2013.05.016

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  188 in total

1.  Effect of number of motor units and muscle fibre type on surface electromyogram.

Authors:  Sridhar Poosapadi Arjunan; Dinesh Kant Kumar; Katherine Wheeler; Hirokazu Shimada; Ariba Siddiqi
Journal:  Med Biol Eng Comput       Date:  2015-07-30       Impact factor: 2.602

2.  Prostate cancer reduces endurance exercise capacity in association with reductions in cardiac and skeletal muscle mass in the rat.

Authors:  Peter J Esau; Elizabeth M Gittemeier; Alexander B Opoku-Acheampong; Korynne S Rollins; Dryden R Baumfalk; David C Poole; Timothy I Musch; Bradley J Behnke; Steven W Copp
Journal:  Am J Cancer Res       Date:  2017-12-01       Impact factor: 6.166

3.  Fenofibrate prevents skeletal muscle loss in mice with lung cancer.

Authors:  Marcus D Goncalves; Seo-Kyoung Hwang; Chantal Pauli; Charles J Murphy; Zhe Cheng; Benjamin D Hopkins; David Wu; Ryan M Loughran; Brooke M Emerling; Guoan Zhang; Douglas T Fearon; Lewis C Cantley
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-08       Impact factor: 11.205

4.  ICU Admission Muscle and Fat Mass, Survival, and Disability at Discharge: A Prospective Cohort Study.

Authors:  Ariel Jaitovich; Malik M H S Khan; Ria Itty; Hau C Chieng; Camille L Dumas; Pallavi Nadendla; John P Fantauzzi; Recai M Yucel; Paul J Feustel; Marc A Judson
Journal:  Chest       Date:  2018-10-28       Impact factor: 9.410

5.  Juzentaihoto hot water extract alleviates muscle atrophy and improves motor function in streptozotocin-induced diabetic oxidative stress mice.

Authors:  Tomoaki Ishida; Michiro Iizuka; Yanglan Ou; Shumpei Morisawa; Ayumu Hirata; Yusuke Yagi; Kohei Jobu; Yasuyo Morita; Mitsuhiko Miyamura
Journal:  J Nat Med       Date:  2018-11-26       Impact factor: 2.343

6.  Muscle-specific activation of calpain system in hindlimb unloading rats and hibernating Daurian ground squirrels: a comparison between artificial and natural disuse.

Authors:  Hui Chang; Tingyun Lei; Xiufeng Ma; Jie Zhang; Huiping Wang; Xingyuan Zhang; Yun-Fang Gao
Journal:  J Comp Physiol B       Date:  2018-07-23       Impact factor: 2.200

7.  Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease. What We Know and Can Do for Our Patients.

Authors:  Ariel Jaitovich; Esther Barreiro
Journal:  Am J Respir Crit Care Med       Date:  2018-07-15       Impact factor: 21.405

Review 8.  Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials.

Authors:  Joe N Kornegay; Christopher F Spurney; Peter P Nghiem; Candice L Brinkmeyer-Langford; Eric P Hoffman; Kanneboyina Nagaraju
Journal:  ILAR J       Date:  2014

9.  Absence of morphological and molecular correlates of sarcopenia in the macaque tongue muscle styloglossus.

Authors:  Alan J Sokoloff; Megan Douglas; Jill A Rahnert; Thomas Burkholder; Kirk A Easley; Qingwei Luo
Journal:  Exp Gerontol       Date:  2016-08-24       Impact factor: 4.032

Review 10.  Skeletal muscle fiber type: using insights from muscle developmental biology to dissect targets for susceptibility and resistance to muscle disease.

Authors:  Jared Talbot; Lisa Maves
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2016-05-19       Impact factor: 5.814

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.